MOTIVATION: A heterogeneous network topology possessing abundant interactions between biomedical entities has yet to be utilized in similarity-based methods for predicting drug-target associations based on the array of varying features of drugs and their targets. Deep learning reveals features of vertices of a large network that can be adapted in accommodating the similarity-based solutions to provide a flexible method of drug-target prediction. RESULTS: We propose a similarity-based drug-target prediction method that enhances existing association discovery methods by using a topology-based similarity measure. DeepWalk, a deep learning method, is adopted in this study to calculate the similarities within Linked Tripartite Network (LTN), a h...
Traditional drug development in wet labs has long been a costly, cumbersome and error-prone process....
The development of new drugs is a time-consuming and labor-intensive process. Therefore, researchers...
Identifying drug targets is a critical step in pharmacology. Drug phenotypic and chemical indexes ar...
The rapidly increasing amount of public data in chemistry and biology provides new opportunities for...
Identifying new disease indications for existing drugs can help facilitate drug development and redu...
<div><p>The rapidly increasing amount of public data in chemistry and biology provides new opportuni...
Abstract Background ...
Abstract Background Disease-drug associations provide essential information for drug discovery and d...
Drug repositioning is a method of systematically identifying potential molecular targets that known ...
The rapidly increasing amount of public data in chemistry and biology provides new opportunities for...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Background: Drug repositioning is an emerging approach in pharmaceutical research for identifying no...
Identifying drug–target interactions is a crucial step in discovering novel drugs and for drug repos...
<div><p>The growing number and variety of genetic network datasets increases the feasibility of unde...
Traditional drug development in wet labs has long been a costly, cumbersome and error-prone process....
The development of new drugs is a time-consuming and labor-intensive process. Therefore, researchers...
Identifying drug targets is a critical step in pharmacology. Drug phenotypic and chemical indexes ar...
The rapidly increasing amount of public data in chemistry and biology provides new opportunities for...
Identifying new disease indications for existing drugs can help facilitate drug development and redu...
<div><p>The rapidly increasing amount of public data in chemistry and biology provides new opportuni...
Abstract Background ...
Abstract Background Disease-drug associations provide essential information for drug discovery and d...
Drug repositioning is a method of systematically identifying potential molecular targets that known ...
The rapidly increasing amount of public data in chemistry and biology provides new opportunities for...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Background: Drug repositioning is an emerging approach in pharmaceutical research for identifying no...
Identifying drug–target interactions is a crucial step in discovering novel drugs and for drug repos...
<div><p>The growing number and variety of genetic network datasets increases the feasibility of unde...
Traditional drug development in wet labs has long been a costly, cumbersome and error-prone process....
The development of new drugs is a time-consuming and labor-intensive process. Therefore, researchers...
Identifying drug targets is a critical step in pharmacology. Drug phenotypic and chemical indexes ar...